The role of androgen receptor in breast cancer

Drug Discovery Today: Disease Mechanisms

Volumn 9, Issue 1-2, 2012, Pages

  Iacopetta, Domenico ^a   Rechoum, Yassine ^b   Fuqua, Suzanne A W ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

BREAST CANCER; CANCER HORMONE THERAPY; CANCER PROGNOSIS; GENOMICS; ONCOGENE NEU; REVIEW; SIGNAL TRANSDUCTION;

EID: 84875228005     PISSN: None     EISSN: 17406765     Source Type: Journal    
DOI: 10.1016/j.ddmec.2012.11.003     Document Type: Review

References (95)

1. F. Moinfar Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies Cancer 98 2003 703 711
2. A.M. Gonzalez-Angulo Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer Clin. Cancer Res. 15 2009 2472 2478
3. S.N. Birrell Androgens induce divergent proliferative responses in human breast cancer cell lines J. Steroid Biochem. Mol. Biol. 52 1995 459 467
4. G. Buchanan Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate Cancer Res. 65 2005 8487 8496
5. A.S. Doane An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen Oncogene 25 2006 3994 4008
6. C.S. Chang Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors Proc. Natl. Acad. Sci. U.S.A. 85 1988 7211 7215
7. K.E. Knudsen, and H.I. Scher Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer Clin. Cancer Res. 15 2009 4792 4798
8. L. Callewaert Interplay between two hormone-independent activation domains in the androgen receptor Cancer Res. 66 2006 543 553
9. C.J. Brown Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism Am. J. Hum. Genet. 44 1989 264 269
10. A.K. Roy Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction Ann. N.Y. Acad. Sci. 949 2001 44 57
11. E.P. Gelmann Molecular biology of the androgen receptor J. Clin. Oncol. 20 2002 3001 3015
12. C.M. Wilson, and M.J. McPhaul A and B forms of the androgen receptor are present in human genital skin fibroblasts Proc. Natl. Acad. Sci. U.S.A. 91 1994 1234 1238
13. M.M. Centenera The contribution of different androgen receptor domains to receptor dimerization and signaling Mol. Endocrinol. 22 2008 2373 2382
14. B. Nicolas Diaz-Chico Androgens and androgen receptors in breast cancer J. Steroid Biochem. Mol. Biol. 105 2007 1 15
15. B.F. Luisi Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA Nature 352 1991 497 505
16. A. Haelens Androgen-receptor-specific DNA binding to an element in the first exon of the human secretory component gene Biochem. J. 353 Pt 3 2001 611 620
17. F. Claessens Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation J. Steroid Biochem. Mol. Biol. 76 2001 23 30
18. A.C. Cato The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region EMBO J. 6 1987 363 368
19. J. Ham Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus Nucl. Acids Res. 16 1988 5263 5276
20. F. Claessens The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors J. Biol. Chem. 271 1996 19013 19016
21. E. Schoenmakers Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains Biochem. J. 341 Pt 3 1999 515 521
22. G. Verrijdt Change of specificity mutations in androgen-selective enhancers, evidence for a role of differential DNA binding by the androgen receptor J. Biol. Chem. 275 2000 12298 12305
23. G. Verrijdt Functional interplay between two response elements with distinct binding characteristics dictates androgen specificity of the mouse sex-limited protein enhancer J. Biol. Chem. 277 2002 35191 35201
24. G. Verrijdt Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element Mol. Endocrinol. 13 1999 1558 1570
25. K. Barbulescu New androgen response elements in the murine pem promoter mediate selective transactivation Mol. Endocrinol. 15 2001 1803 1816
26. K. Steketee A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron J. Mol. Endocrinol. 33 2004 477 491
27. E.C. Bolton Cell- and gene-specific regulation of primary target genes by the androgen receptor Genes Dev. 21 2007 2005 2017
28. C.E. Massie New androgen receptor genomic targets show an interaction with the ETS1 transcription factor EMBO Rep. 8 2007 871 878
29. Q. Wang A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth Mol. Cell 27 2007 380 392
30. M.J. McPhaul Androgen resistance caused by mutations in the androgen receptor gene FASEB J. 5 1991 2910 2915
31. N. Honma Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years J. Clin. Endocrinol. Metab. 91 2006 607 613
32. J.R. Pasqualini, and G.S. Chetrite Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer J. Steroid Biochem. Mol. Biol. 93 2005 221 236
33. G.S. Chetrite Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues J. Steroid Biochem. Mol. Biol. 72 2000 23 27
34. I.U. Agoulnik, and N.L. Weigel Androgen receptor action in hormone-dependent and recurrent prostate cancer J. Cell. Biochem. 99 2006 362 372
35. Z.X. Zhou A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences J. Biol. Chem. 269 1994 13115 13123
36. M. Thomas Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts J. Biol. Chem. 279 2004 8389 8395
37. N. Mononen Androgen receptor CAG polymorphism and prostate cancer risk Hum. Genet. 111 2002 166 171
38. N. Harada Involvement of three glutamine tracts in human androgen receptor transactivation J. Steroid Biochem. Mol. Biol. 118 2010 77 84
39. H. Yu Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer Breast Cancer Res. Treat. 59 2000 153 161
40. Y.A. Elhaji The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40 Breast Cancer Res. Treat. 70 2001 109 116
41. C. Iobagiu Microsatellite profile in hormonal receptor genes associated with breast cancer Breast Cancer Res. Treat. 95 2006 153 159
42. W. Wang Androgen receptor and prostate-specific antigen gene polymorphisms and breast cancer in African-American women Cancer Epidemiol. Biomarkers Prev. 14 2005 2990 2994
43. F. Rahman, and H.C. Christian Non-classical actions of testosterone: an update Trends Endocrinol. Metab. 18 2007 371 378
44. P. Farmer Identification of molecular apocrine breast tumours by microarray analysis Oncogene 24 2005 4660 4671
45. K.M. Chia A feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer Neoplasia 13 2011 154 166
46. A. Naderi Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer Breast Cancer Res. 13 2011 R36
47. M. Ni Targeting androgen receptor in estrogen receptor-negative breast cancer Cancer Cell 20 2011 119 131
48. B.D. Lehmann Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies J. Clin. Invest. 121 2011 2750 2767
49. J.L. Robinson Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1 EMBO J. 30 2011 3019 3027
50. L.C. Collins Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study Mod. Pathol. 24 2011 924 931
51. J.R. Garreau Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulation Am. J. Surg. 191 2006 576 580
52. M. Lin Fde Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity J. Clin. Pathol. 65 2012 64 68
53. A. Cimino-Mathews Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy Hum. Pathol. 43 2012 1003 1011
54. J.P. Garay The growth response to androgen receptor signaling in ERalpha-negative human breast cells is dependent on p21 and mediated by MAPK activation Breast Cancer Res. 14 2012 R27
55. S. Lu Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter Mol. Endocrinol. 13 1999 376 384
56. T.R. Graham Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells Breast Cancer Res. Treat. 123 2010 139 147
57. Y. Wang Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers Oncogene 30 2011 4327 4338
58. Y. Wang GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer Hum. Mol. Genet. 21 2012 569 576
59. L.C. Singh Study on predictive role of AR and EGFR family genes with response to neoadjuvant chemotherapy in locally advanced breast cancer in Indian women Med. Oncol. 29 2012 539 546
60. J.J. Park Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor Cancer Res. 60 2000 5946 5949
61. G. Pristauz Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations Histopathology 57 2010 877 884
62. R. Hu Androgen receptor expression and breast cancer survival in postmenopausal women Clin. Cancer Res. 17 2011 1867 1874
63. S. Park Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers Ann. Oncol. 22 2011 1755 1762
64. J.P. Qi Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients Breast Cancer (Auckl) 6 2012 1 8
65. J. He Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray Med. Oncol. 29 2012 406 410
66. S. Loibl Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy Breast Cancer Res. Treat. 130 2011 477 487
67. L.A. Niemeier Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation Mod. Pathol. 23 2010 205 212
68. H. Soiland Prognostic relevance of androgen receptor detection in operable breast cancer J. Surg. Oncol. 98 2008 551 558
69. O.A. Lea Improved measurement of androgen receptors in human breast cancer Cancer Res. 49 Pt 1 1989 7162 7167
70. R.A. Smith Detection of mRNA levels for the estrogen alpha, estrogen beta and androgen nuclear receptor genes in archival breast cancer tissue Cancer Lett. 237 2006 248 255
71. G.A. Hospers PET imaging of steroid receptor expression in breast and prostate cancer Curr. Pharm. Des. 14 2008 3020 3032
72. C. Riva Immunohistochemical study of androgen receptors in breast carcinoma, evidence of their frequent expression in lobular carcinoma Virchows Arch. 447 2005 695 700
73. E.M. Berns Androgen pathway dysregulation in BRCA1-mutated breast tumors Breast Cancer Res. Treat. 79 2003 121 127
74. B. Liegl Androgen receptors are frequently expressed in mammary and extramammary Paget's disease Mod. Pathol. 18 2005 1283 1288
75. V. Kuenen-Boumeester The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters Eur. J. Cancer 32A 1996 1560 1565
76. F. De Amicis Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells Breast Cancer Res. Treat. 121 2010 1 11
77. K. Hanley Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast Hum. Pathol. 39 2008 386 392
78. W. Schippinger Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer Virchows Arch. 449 2006 24 30
79. A.A. Peters Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer Cancer Res. 69 2009 6131 6140
80. I. Castellano Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers Breast Cancer Res. Treat. 124 2010 607 617
81. C. Lohrisch, and M. Piccart HER2/neu as a predictive factor in breast cancer Clin. Breast Cancer 2 2001 129 135 discussion 136-127
82. E.A. Rakha Prognostic markers in triple-negative breast cancer Cancer 109 2007 25 32
83. A. Goldhirsch Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 Ann. Oncol. 20 2009 1319 1329
84. G.D. Lewis Phillips Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate Cancer Res. 68 2008 9280 9290
85. W.R. Miller Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter? Oncologist 13 2008 829 837
86. C. Hardin A new hormonal therapy for estrogen receptor-negative breast cancer World J. Surg. 31 2007 1041 1046
87. S.N. Birrell Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression J. Clin. Oncol. 13 1995 1572 1577
88. F.A. Teulings Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer Cancer Res. 40 1980 2557 2561
89. S.N. Birrell Role of the androgen receptor in human breast cancer J. Mammary Gland Biol. Neoplasia 3 1998 95 103
90. F. Labrie Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone Endocr. Rev. 24 2003 152 182
91. L.F. Macedo Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole Cancer Res. 66 2006 7775 7782
92. H. Yamashita Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer Cancer Sci. 100 2009 2028 2033
93. Z. Khalkhali-Ellis Regulating the tumor suppressor gene maspin in breast cancer cells: a potential mechanism for the anticancer properties of tamoxifen Clin. Cancer Res. 10 2004 449 454
94. T.P. Zhao, and G.F. He A phase II clinical trial of flutamide in the treatment of advanced breast cancer Tumori 74 1988 53 56
95. M. Di Monaco Inhibitory effect of hydroxyflutamide plus tamoxifen on oestradiol-induced growth of MCF-7 breast cancer cells J. Cancer Res. Clin. Oncol. 121 1995 710 714